Cite
HARVARD Citation
Eerdekens, M. et al. (2019). Cancer‐related chronic pain: Investigation of the novel analgesic drug candidate cebranopadol in a randomized, double‐blind, noninferiority trial. European journal of pain. pp. 577-588. [Online].